TRIM46 and nonpapillary renal cell carcinoma: Thirdly, the potential mechanisms involved in the effects of TRIM46 on the clinical outcome of ccRCC patients were not fully explored (concerned with cell proliferation, or metabolic reprogramming, or immune infiltrates, immunosuppression, or both)?